GSK says antibody drug 'Sotrovimab' works against Omicron

UK's Medicines and Healthcare products Regulatory Agency has approved sotrovimab, a Covid-19 treatment which has been developed by GSK and Vir Biotechnology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZQCtuw
via IFTTT